The FDA has responded to the increasing use of artificial intelligence (AI) in the discovery and development of drugs and ...

The result is another major disappointment to ALS patients, who have limited drug treatment options at present, particularly ...

Where early enthusiasm around IDMP programmes had waned in response to slow progress from EMA in Europe towards clarifying ...

The unidentified man is one of 66 confirmed human cases of H5N1 bird flu in the US since 2024, when the current outbreak took ...

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare ...

Now, in 2025, we expect the life sciences industry will scale its use of GenAI with greater purpose. As these applications ...

1. Proactively identify barriers to medication adherence, including identifying and targeting patients who may be ...

Fortunately, my home isn't too far from Stamford Bridge stadium, making it easy to catch the action live! Connect with Peter ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung cancer (SCLC), with the EMA awarding Priority Medicine (PRIME) status to the ...